Target intelligence / Profile preview

Mediator complex subunit 28 (MED28)

Target
MED28
Molecular classification
Transcriptional coactivator (Mediator complex), Mediator complex subunit, Other (cytosolic binding partner, actin-binding)
01

Overview

Mediator complex subunit 28 (MED28) is a protein component of the multi-subunit Mediator complex that serves as a crucial coactivator for RNA polymerase II transcription in eukaryotic cells. MED28 acts as a bridge transmitting signals from gene-specific regulatory factors to the basal transcription machinery, assisting in the assembly of the preinitiation complex. In addition to its nuclear role, MED28 interacts cytosolically with merlin (NF2), participating in actin cytoskeleton signaling and cellular migration. MED28 is essential for peri-implantation development, maintenance and acquisition of embryonic stem cell pluripotency, and plays a role in regulating cell differentiation, especially repressing smooth muscle differentiation. Mutations or dysregulation have been associated with certain cancers (especially breast cancer, via MEK1-dependent migration), and genetic diseases such as severe congenital neutropenia and schwannomatosis. There are currently no drugs or established clinical biomarkers directly targeting MED28.

Other names
Mediator of RNA polymerase II transcription subunit 28EG1FKSG20MagicinDKFZP434N185Endothelial-derived protein 1Merlin and Grb2-interacting cytoskeletal proteinTumor angiogenesis marker EG-11500003D12Rikendothelial-derived gene 1
02

Biological functions

Transcription regulation (RNA polymerase II)Scaffold for preinitiation complex assemblyRegulation of cell fate and developmentNegative regulation of smooth muscle cell differentiationActin-binding and cytoskeletal signalingMaintenance and acquisition of pluripotency in embryonic stem cells
03

Disease associations

Cancer (polyfunctionality, role in breast cancer cell migration and signaling)Severe congenital neutropeniaSchwannomatosisOther: Embryonic development and stem cell pluripotency

Beyond the preview

Go deeper on Mediator complex subunit 28 (MED28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mediator complex subunit 28 (MED28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call